I want to make something clear.
They do look at diseases. They've looked at one out of 10, and they have a plan to get the other nine out of 10 done by 2020. They're not looking at new and emerging diseases. That is obviously a concern, but to say they're not doing anything on that issue I think goes a bit too far.